August 30, 2018 — At the 2018 European Society of Cardiology (ESC) Congress, cardiovascular technology startup Maisense debuted the Freescan telecardiology system that uses a portable device to measure blood pressure and record electrocardiogram (ECG) readings simultaneously.
Maisense Vice President of Business Development Bach Chen noted that most telecardiology systems on the market either provide only ECG, or provide both blood pressure and ECG but retrieve them from two independent devices. Chen said that the more devices there are, the less likely it becomes that patients will use all of them regularly.
The purpose of Maisense's telecardiology system is to simplify the measurement procedure for patients. Through the combination of three elements — the Freescan device, the myFreescan App and the Patient Care web platform — patients can measure blood pressure and ECG with a single device. In addition, doctors are able to monitor patients' health condition easily through the web-based Patient Care System. Maisense Freescan in combination with the myFreescan App utilizes artificial intelligence (AI) for early atrial fibrillation detection (AFib), arrhythmia (bradycardia and tachycardia) detection, pulse wave velocity and blood pressure monitoring in a single device.
According to the World Health Organization (WHO)'s May 2018 report, stroke incidents are globally the second most common cause of death after ischemic heart disease. Of the 56.9 million deaths worldwide in 2016, almost 6 million people died of strokes — about 10 percent of all the accounted deaths. However, up to 80 percent of strokes may be preventable by monitoring the major risk factors: arterial stiffness, AFib and hypertension.
The adoption of Maisense's telecardiology system will enable every user of the solution to assess their risk level of strokes anytime, according to the company. Therefore then they can take preventive actions to minimize the risk.
For more information: www.maisense.com